Y10S514/812 - CPC Classification Index

#1

20180214443

2018-08-02

Pharmaceutical preparation containing oxycodone and naloxone

#2

20170112828

2017-04-27

Pharmaceutical preparation containing oxycodone and naloxone

#3

20150024035

2015-01-22

Method and system for synthesizing nanocarrier based long acting drug delivery system for methadone

#4

20150024033

2015-01-22

Method and system for synthesizing nanocarrier based long acting drug delivery system for buprenorphine

#5

20150005335

2015-01-01

Matrix for sustained, invariant and independent release of active compounds

#6

20140357658

2014-12-04

Opioid agonist/opioid antagonist/acetaminophen combinations

#7

20140296277

2014-10-02

Pharmaceutical preparation containing oxycodone and naloxone

#8

20140200236

2014-07-17

Opioid agonist/antagonist combinations

#9

20140045878

2014-02-13

Matrix for sustained, invariant and independent release of active compounds

#10

20130165418

2013-06-27

Opioid agonist/opioid antagonist/acetaminophen combinations

#11

20120183612

2012-07-19

Matrix for sustained, invariant and independent release of active compounds

#12

20120165359

2012-06-28

Opioid agonist/antagonist combinations

#13

20120108621

2012-05-03

PHARMACEUTICAL PREPARATION CONTAINING OXYCODONE AND NALOXONE

#14

20100291203

2010-11-18

Opioid agonist/antagonist combinations

#15

20090221714

2009-09-03

Pharmaceutical composition for prevention and treatment of drug or alcohol addiction or bipolar disorder using sodium phenylbutyrate

#16

20080292694

2008-11-27

Opioid agonist/antagonist combinations

#17

20080200370

2008-08-21

Method of treating drug addiction using dextro-morphine

#18

20070122348

2007-05-31

Opioid agonist/antagonist combinations

#19

20060069113

2006-03-30

Analgesic compositions containing buprenorphine

#20

20060058333

2006-03-16

Analgesic compositions containing buprenorphine

#21

20060058332

2006-03-16

Analgesic compositions containing buprenorphine

#22

20060014837

2006-01-19

Use of the (1S, 2R) enantiomer of milnacipran for the preparation of a drug

#23

20050245556

2005-11-03

Pharmaceutical preparation containing oxycodone and naloxone

#24

20050245483

2005-11-03

Matrix for sustained, invariant and independent release of active compounds

#25

20050192309

2005-09-01

Method of preventing abuse of opioid dosage forms

#26

20050181974

2005-08-18

Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists

#27

20050163865

2005-07-28

Enkephalinase inhibitor and GABA precursor loading as anti-anxiety compositions

#28

20050074504

2005-04-07

Use of borate-polyol complexes in ophthalmic compositions